Control and Function of Histone H3 Lysine 27 Methylation in Neurospora
脉孢菌中组蛋白 H3 赖氨酸 27 甲基化的控制和功能
基本信息
- 批准号:8295616
- 负责人:
- 金额:$ 26.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAnimalsArabidopsisBindingBinding SitesBiochemicalCaenorhabditis elegansCatalytic DomainChIP-on-chipChIP-seqCharacteristicsChromatinCis-Acting SequenceCollectionComplexDNA MethylationDevelopmentDrosophila genusElementsEpigenetic ProcessEukaryotaFission YeastGene ExpressionGene SilencingGenesGeneticGenomeGenomic ImprintingHeritabilityHistone H3HistonesHomologous GeneHumanIn VitroKineticsLeadLysineMaintenanceMalignant NeoplasmsMammalsMapsMethodsMethylationMethyltransferaseModelingModificationMolecular GeneticsNeurosporaNeurospora crassaOrganismPRC1 ProteinPeptidesPhasePlantsPlayPolycombProcessProteinsProteomicsReadingReportingRepressionResearchResearch PersonnelRoleSaccharomyces cerevisiaeSignal TransductionSiteSportsSystemTertiary Protein StructureTestingTherapeutic InterventionTranscription ElongationTranscription InitiationWorkX InactivationYeastsbasechromatin proteinflyfollow-upgene repressionin vivoinsightmembermutantplant fungiprotein complexresearch studytelomeretumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Normal development of animals, plants and fungi rely heavily on chromatin-based signals. The proposed research focuses on a particularly central example, trimethylation of histone H3 Lysine 27 (H3K27me3). Work in flies, mammals and plants have implicated this mark in long-term repression of genes in development, as well as in X-inactivation, genomic imprinting and cancer. Details of how H3K27me3 functions and how it is controlled remain unknown, however. The recent discovery of regions of H3K27me3 in the genome of the simple eukaryote, Neurospora crassa, and identification of elements of the underlying methylation machinery in this organism provide an opportunity to apply the exceptional power of Neurospora molecular and genetic methods to explore the function and control of this histone mark. H3K27me3 has not been found in other simpler systems (e.g. yeasts). Specific aims of the project are: 1. To test for heritability of H3K27me3 and to determine the kinetics of de novo K27 methylation. We will test if methylation of H3K27 induced at an ectopic site is maintained after the inducing construct is removed. We will also use genetic and molecular methods to determine the kinetics of de novo H3K27 methylation. 2. To identify the components of the H3K27 methylation machinery. We will characterize the K27 methyltransferase complex and investigate what reads the H3K27me3 mark. Candidate binders (chromo domain proteins and the SET-7 complex) will be tested and proteomic and genetic (mutant hunt) methods will be used to identify unsuspected elements of the machinery. 3. To identify cis-acting sequences that control H3K27me3. To address the possibility that H3K27me3 in Neurospora is directed by sequences comparable to PREs of Drosophila, we will: a. use ChIP-Seq. to map binding sites of Neurospora PRC2 components; b. test deletions of native H3K27me3 regions for loss of H3K27me; c. test candidate control regions for the ability to direct H3K27 methylation at an ectopic site. 4. To define the role and mechanism of H3K27 methylation in gene repression. We will explore conditions that may control K27me3 genes and determine whether repression by K27 methylation results from a block in transcription initiation or elongation. 5. To test whether the SET-7 complex reads histone marks. We will explore the possibility that the SET-7 complex is sensitive to modifications in the N-terminus of H3 in vivo using our collection of mutants, and if the complex is found to bind H3K27me in vitro, we will follow up by testing it's binding to modified peptides.
PUBLIC HEALTH RELEVANCE: Trimethylation of the lysine 27 residue of histone H3 plays a critical role in the epigenetic repression of genes during development, X-inactivation, genomic imprinting, and the aberrant inactivation of genes in cancer. Understanding how this epigenetic mark is regulated will lead to better insight of its role in tumorigenesis and ultimately to the development of therapeutic interventions. Neurospora crassa is the simplest model organism known to have the H3K27me3 mark and provides a system in which to make great strides in our understanding of the H3K27me3 mark.
描述(由申请人提供):动物,植物和真菌的正常发育严重依赖于基于染色质的信号。拟议的研究重点是一个特别中心的例子,即组蛋白H3赖氨酸27(H3K27ME3)的三甲基化。果蝇,哺乳动物和植物的工作使这一标记在长期抑制发育中的基因以及X灭活,基因组印迹和癌症中。然而,H3K27ME3的功能及其如何控制的详细信息仍然未知。在简单真核生物,神经孢子骨的基因组中发现了H3K27me3区域的最新发现,并鉴定了这种生物体中潜在甲基化机制的元素,这提供了一个机会,可以运用神经孢子的分子和遗传方法的特殊力量,以探索这种历史蛋白的功能和控制功能和控制。 H3K27me3在其他更简单的系统(例如酵母)中尚未发现。该项目的具体目的是:1。测试H3K27me3的遗传力并确定从头K27甲基化的动力学。我们将测试在去除诱导构建体后,在异位部位诱导的H3K27的甲基化是否维持。我们还将使用遗传和分子方法来确定从头H3K27甲基化的动力学。 2。确定H3K27甲基化机制的组件。我们将表征K27甲基转移酶复合物,并研究读取H3K27me3标记的内容。将测试候选粘合剂(Chromo域蛋白和SET-7复合物),并将使用蛋白质组学和遗传(突变狩猎)方法来识别机械的未经引起的元素。 3。识别控制H3K27me3的顺式作用序列。为了解决Neurospora中H3K27me3的可能性,由与果蝇的序列相当的序列指向,我们将:使用chip-seq。绘制神经孢子prc2成分的结合位点; b。 H3K27ME损失的天然H3K27ME3区域的测试缺失; c。测试候选控制区,可在异位部位指导H3K27甲基化的能力。 4。定义H3K27甲基化在基因抑制中的作用和机制。我们将探索可能控制K27me3基因的条件,并确定K27甲基化抑制是否是由于转录起始或伸长率的块而导致的。 5。测试Set-7复合物是否读取组蛋白标记。我们将探讨使用我们的突变体集合在体内H3中的Set-7复合物对H3的N末端的修饰敏感的可能性,并且如果发现该复合物可以在体外结合H3K27ME,我们将通过测试其与改性肽的结合来跟进。
公共卫生相关性:赖氨酸27组蛋白H3残基的三甲基化在发育,X灭活,基因组印记和癌症基因的异常失活过程中对基因的表观遗传抑制至关重要。了解这种表观遗传标记的调节将如何更好地了解其在肿瘤发生中的作用,并最终导致治疗干预措施的发展。 Neurospora crassa是已知具有H3K27me3标记的最简单模型生物,并提供了一个系统,可以在我们对H3K27me3标记的理解中取得长足进步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric U. SELKER其他文献
Eric U. SELKER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric U. SELKER', 18)}}的其他基金
Control and function of heterochromatin in Neurospora crassa
粗糙脉孢菌异染色质的控制和功能
- 批准号:
10226222 - 财政年份:2018
- 资助金额:
$ 26.93万 - 项目类别:
Control and function of heterochromatin in Neurospora crassa
粗糙脉孢菌异染色质的控制和功能
- 批准号:
9763633 - 财政年份:2018
- 资助金额:
$ 26.93万 - 项目类别:
Control and function of heterochromatin in Neurospora crassa
粗糙脉孢菌异染色质的控制和功能
- 批准号:
10456331 - 财政年份:2018
- 资助金额:
$ 26.93万 - 项目类别:
Control and Function of Histone H3 Lysine 27 Methylation in Neurospora
脉孢菌中组蛋白 H3 赖氨酸 27 甲基化的控制和功能
- 批准号:
8690099 - 财政年份:2012
- 资助金额:
$ 26.93万 - 项目类别:
Control and Function of Histone H3 Lysine 27 Methylation in Neurospora
脉孢菌中组蛋白 H3 赖氨酸 27 甲基化的控制和功能
- 批准号:
8454417 - 财政年份:2012
- 资助金额:
$ 26.93万 - 项目类别:
Gordon Conference--Epigenetic Effects of Gene Expression
戈登会议--基因表达的表观遗传效应
- 批准号:
6361732 - 财政年份:2001
- 资助金额:
$ 26.93万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Effects of tACS on alcohol-induced cognitive and neurochemical deficits
tACS 对酒精引起的认知和神经化学缺陷的影响
- 批准号:
10825849 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10556857 - 财政年份:2023
- 资助金额:
$ 26.93万 - 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 26.93万 - 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 26.93万 - 项目类别: